2′-Iodoacetophenone - China Manufacturers, Suppliers, Factory

2′-Iodoacetophenone, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

2'-Iodoacetophenone CAS 2142-70-3 Purity 98.0 (GC) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2'-Iodoacetophenone CAS 2142-70-3 Purity >98.0% (GC)
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...

2022.10.25 04:09:49
2022.08.12 03:10:26
2022.04.07 00:32:12
2022.03.11 10:22:24
2022.02.09 20:05:57
2022.01.12 21:02:41

2′-Iodoacetophenone - China Manufacturers, Suppliers, Factory

Related Products

2'-Iodoacetophenone CAS 2142-70-3 Purity >98.0% (GC)

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

(S)-1-Phenyl-1,2,3,4-Tetrahydroisoquinoline CAS 118864-75-8 Purity ≥99.5% Factory

1-Pyreneboronic Acid CAS 164461-18-1 Purity >95.0% Factory High Quality

3-Indoleacrylic Acid (IAA) CAS 1204-06-4 Purity >99.0% (HPLC) Factory High Quality

Fmoc-NH2 CAS 84418-43-9 9-Fluorenylmethyl Carbamate Purity >99.0% (HPLC) Factory

N-Acetyl-DL-Glutamic Acid CAS 5817-08-3 Ac-DL-Glu-OH Purity >98.0% (HPLC)

Z-D-Asp(OBzl)-OH CAS 5241-62-3 Z-D-Aspartic Acid β-Benzyl Ester Purity >98.0% (HPLC)

β-D-Ribofuranose 1,2,3,5-Tetraacetate CAS 13035-61-5 Assay 98.0%~102.0% (UV) High Purity

4-Hydrazinylpyridine Hydrochloride CAS 20815-52-5 Purity ≥97.0%

Bis(pinacolato)diboron CAS 73183-34-3 Purity >99.5% (GC) Factory Hot Sale

Ethyl (Ethoxymethylene)cyanoacetate CAS 94-05-3 Purity ≥99.0% (GC)

BMIMBF4 CAS 174501-65-6 Purity ≥99.0% (HPLC) Factory Main Product

Boc-11-Aun-OH CAS 10436-25-6 Boc-11-Aminoundecanoic Acid Purity >98.0% (HPLC)

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Xi presents award to top scientists

Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The “Summit on COVID-19 Diagnostics & Treatment”

New COVID treatments offer hope

2022.10.25 04:09:49

2022.08.12 03:10:26

2022.04.07 00:32:12

2022.03.11 10:22:24

2022.02.09 20:05:57

2022.01.12 21:02:41

related search